APA (7th ed.) Citation

P, C., M, M., F, G., F, F., C, S., F, L., . . . C, P. (2026). Venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogeneic HSCT. Bone marrow transplantation, 61(1), 101. https://doi.org/10.1038/s41409-025-02723-x

Chicago Style (17th ed.) Citation

P, Chiusolo, et al. "Venetoclax Plus Hypomethylating Agents as First Salvage Therapy for Myeloid Malignancies Relapsing After Allogeneic HSCT." Bone Marrow Transplantation 61, no. 1 (2026): 101. https://doi.org/10.1038/s41409-025-02723-x.

MLA (9th ed.) Citation

P, Chiusolo, et al. "Venetoclax Plus Hypomethylating Agents as First Salvage Therapy for Myeloid Malignancies Relapsing After Allogeneic HSCT." Bone Marrow Transplantation, vol. 61, no. 1, 2026, p. 101, https://doi.org/10.1038/s41409-025-02723-x.